Fundraising Fox
/Companies
Sign in

Cellarity

Founded 2017 · 66 employees on LinkedIn · 4 known investors

Find your way into Cellarity

Sign up to find every way you can get introduced to Cellarity

  • Your email: who you already know at Cellarity, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Cellarity team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Cellarity develops medicines using artificial intelligence and single-cell biology to address disease at the cellular level rather than targeting individual disease markers. The company serves patients with challenging diseases through AI-driven drug discovery.

AI & Machine LearningBiotechDeep TechMedical Devices

Investors · 4

Flagship Pioneeringlisted by Flagship PioneeringCambridge · $500K – $10M

How we know: Flagship Pioneering's portfolio page · a partner's Signal profile · funding news · Not right? Tell us

Manta Ray Ventureslisted by Manta Ray VenturesLondon

How we know: Manta Ray Ventures's portfolio page · Not right? Tell us

BlackRockreportedMexico City

How we know: funding news · Not right? Tell us

Funding

SEC filings, press & company announcements

$244M disclosed across 2 of 4 rounds · 2021–2024

Source: company announcements and press reports — follow each round's link for the claim.

Founder mafia

4 people who came through Cellarity went on to found or lead other companies.

Noubar AfeyanCo-Founder and ChairmanFounded ProFound Therapeutics +15Avak KahvejianBoard MemberFounded ProFound Therapeutics +5Alex WolfAssociate Director, Machine LearningFounded LaminSunny SunSenior Scientist, Computational BiologyFounded Lamin

In the news

Cellarity Closes $121M Series C Financingfinsmes.com · Oct 2022

Frequently asked questions

What does Cellarity do?
Cellarity develops medicines using artificial intelligence and single-cell biology to address disease at the cellular level rather than targeting individual disease markers. The company serves patients with challenging diseases through AI-driven drug discovery.
Who are Cellarity's investors?
Cellarity's investors include Ahren Innovation Capital, Flagship Pioneering, Manta Ray Ventures, BlackRock.
How much funding has Cellarity raised?
Cellarity has disclosed $244M raised across 2 of its 4 known rounds.